Fingerprint
Dive into the research topics of 'Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children
ILLUMINATE-B Workgroup
Research output: Contribution to journal › Article › peer-review